$44.39
-4.27-8.78%
At close: -
$45.15
0.761.72%
After Hours: Nov 15, 4:21 PM EDT
Comments
Loading...
Biohaven (BHVN) Forecast
NewsEarningsBiohaven (BHVN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBiohaven (NYSE:BHVN) Stock Quotes, Forecast and News Summary
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biohaven (BHVN) stock?
You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.
Who are Biohaven (BHVN) competitors?
Other companies in Biohaven’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Biohaven (BHVN) stock?
Biohaven has a consensus price target of $78.44.
What is the current price for Biohaven (BHVN)?
The stock price for Biohaven (NYSE: BHVN) is $45.152 last updated November 15, 2024 at 4:21 PM EST.
Does Biohaven (BHVN) pay a dividend?
There are no upcoming dividends for Biohaven.
When is Biohaven (NYSE:BHVN) reporting earnings?
Biohaven’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Biohaven (BHVN) going to split?
There is no upcoming split for Biohaven.
What sector and industry does Biohaven (BHVN) operate in?
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.